Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Cash from Investing Activities (2016 - 2025)

Myriad Genetics (MYGN) has disclosed Cash from Investing Activities for 17 consecutive years, with -$6.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Investing Activities fell 1.69% to -$6.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$27.4 million, a 130.25% decrease, with the full-year FY2025 number at -$27.4 million, down 130.25% from a year prior.
  • Cash from Investing Activities was -$6.0 million for Q4 2025 at Myriad Genetics, up from -$6.2 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $291.0 million in Q3 2021 to a low of -$41.3 million in Q1 2022.
  • A 5-year average of $9.5 million and a median of -$6.1 million in 2025 define the central range for Cash from Investing Activities.
  • Peak YoY movement for Cash from Investing Activities: skyrocketed 1601.75% in 2021, then tumbled 1190.91% in 2022.
  • Myriad Genetics' Cash from Investing Activities stood at -$25.9 million in 2021, then plummeted by 37.45% to -$35.6 million in 2022, then soared by 66.29% to -$12.0 million in 2023, then surged by 50.83% to -$5.9 million in 2024, then fell by 1.69% to -$6.0 million in 2025.
  • Per Business Quant, the three most recent readings for MYGN's Cash from Investing Activities are -$6.0 million (Q4 2025), -$6.2 million (Q3 2025), and -$6.9 million (Q2 2025).